Pharsight

Btcp Pharma patents expiration

1. Lazanda patents expiration

LAZANDA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9814705 BTCP PHARMA Intranasal spray device containing pharmaceutical composition
Jan, 2024

(2 months ago)

US9078814 BTCP PHARMA Intranasal spray device containing pharmaceutical composition
Jan, 2024

(2 months ago)

US8889176 BTCP PHARMA Method of managing or treating pain
Jan, 2024

(2 months ago)

US8216604 BTCP PHARMA Method of managing or treating pain
Oct, 2024

(6 months from now)

US9731869 BTCP PHARMA Container
Jan, 2032

(7 years from now)

Drugs and Companies using FENTANYL CITRATE ingredient

Market Authorisation Date: 30 June, 2011

Treatment: Management of breakthrough pain in patients with cancer

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

LAZANDA family patents

Family Patents

2. Subsys patents expiration

SUBSYS Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610523 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(2 years from now)

US8835459 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(2 years from now)

US10016403 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(2 years from now)

US9241935 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(2 years from now)

US8835460 BTCP PHARMA Sublingual fentanyl spray and methods of treating pain
Jan, 2027

(2 years from now)

US9642797 BTCP PHARMA Sublingual fentanyl spray and methods of use to treat pain
Jan, 2027

(2 years from now)

US9289387 BTCP PHARMA Method of treating pain by administering sublingual fentanyl spray
Jan, 2027

(2 years from now)

US9642844 BTCP PHARMA Sublingual fentanyl spray
Jan, 2027

(2 years from now)

US8486973 BTCP PHARMA Sublingual fentanyl spray
Apr, 2030

(6 years from now)

US8486972 BTCP PHARMA Sublingual fentanyl spray
Apr, 2030

(6 years from now)

Drugs and Companies using FENTANYL ingredient

Market Authorisation Date: 04 January, 2012

Treatment: Treatment of pain

Dosage: SPRAY;SUBLINGUAL

How can I launch a generic of SUBSYS before it's drug patent expiration?
More Information on Dosage

SUBSYS family patents

Family Patents